m-Chloroperbenzoic acid → HCID 178440859, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[N:4][CH:5]=[CH:6][C:7]=1/[C:8](/[CH2:31][CH3:32])=[C:9](\[C:20]1[CH:25]=[CH:24][C:23](/[CH:26]=[CH:27]/[C:28]([OH:30])=[O:29])=[CH:22][CH:21]=1)/[C:10]1[CH:11]=[C:12]2[C:16](=[C:17]([F:19])[CH:18]=1)[NH:15][N:14]=[CH:13]2.C1C=C(Cl)C=C(C(OO)=[O:41])C=1>ClCCl>[C:28](/[CH:27]=[CH:26]/[C:23]1[CH:24]=[CH:25][C:20](/[C:9](/[C:10]2[CH:11]=[C:12]3[C:16](=[C:17]([F:19])[CH:18]=2)[NH:15][N:14]=[CH:13]3)=[C:8](\[C:7]2[CH:6]=[CH:5][N+:4]([O-:41])=[CH:3][C:2]=2[Cl:1])/[CH2:31][CH3:32])=[CH:21][CH:22]=1)([OH:30])=[O:29]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of (E)-3-(4-((E)-2-(3-chloropyridin-4-yl)-1-(7-fluoro-1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid (14.1 mg, 0.031 mmol, Compound 245), mCPBA (11 mg, 0.048 mmol), and dichloromethane (0.5 mL) was stirred vigorously for 15 h. Additional starting material (20 mg, 0.045 mmol) and mCPBA (15 mg, 0.065 mmol) were added and stirring was continued for 3 d. The reaction was concentrated and then purified by reverse-phase HPLC(CH3CN, H2O, TFA) to give 4-((E)-1-(4-((E)-2-carboxyvinyl)phenyl)-1-(7-fluoro-1H-indazol-5-yl)but-1-en-2-yl)-3-chloropyridine-1-oxide. 1H NMR (400 MHz, DMSO-d6): δ 8.44 (d, 1H), 8.25 (d, 1H), 8.16 (dd, 2H), 7.56 (s, 1H), 7.50-7.42 (m, 4H), 7.05-6.96 (m, 3H), 6.43 (d, 1H), 2.41 (q, 2H), 0.94 (t, 3H); LCMS: 464.0 (M+H)+.
Workup
- additionwere added
- stirringstirring
- waitwas continued for 3 d
- concentrationThe reaction was concentrated
- custompurified by reverse-phase HPLC(CH3CN, H2O, TFA)
Sources & evidence
- ORD record
- ord-38982e5a2bdd414db33587acec087f87
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09399646B2
Reaction notes
Loading…